Stimulants were involved in 46.2% of drug use-associated infective endocarditis hospitalizations in 2022, up from 37.3% in 2016, according to a study published Oct. 27 in Clinical Infectious Diseases. Researchers from the University of Colorado School of Medicine in Aurora, Washington University School of Medicine in St. Louis, University of California San Francisco and Boston University Chobanian and Avedisian School of Medicine analyzed National Inpatient Sample data. The data represented an estimated 118,190 hospitalizations nationwide from 2016 to 2022. Here are five things to know: 1. Drug use-associated endocarditis hospitalizations… Originally published in Becker’s Hospital Review. Read More
Stimulants tied to 46% of drug-related endocarditis hospitalizations: Study
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT